Click for best price
Insomnia Treatment Drugs Market Size, Share 2022
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
This report contains market size and forecasts of Insomnia Treatment Drugs in Global, including the following market information:
Global top five companies in 2021 (%)
The global Insomnia Treatment Drugs market was valued at 3006.2 million in 2021 and is projected to reach US$ 3764 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Sleep Aids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insomnia Treatment Drugs include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insomnia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
- Prescription Sleep Aids
- Over the Counter (OTC) Sleep Aids
Global Insomnia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Global Insomnia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Insomnia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Insomnia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Insomnia Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F.Hoffman La-Roche AG
- Merck & Co. Inc.
- Mylan N.V.
- Pfizer, Inc.
- Pernix Therapeutics
- Sanofi S.A.
- Takeda Pharmaceutical Company Ltd.
- Sumitomo Dainippon Pharma Co., Ltd
- Teva Pharmaceutical Industries Ltd.
- Vanda Pharmaceuticals, Inc.
| Report Attributes |
Report Details |
| Report Title |
Insomnia Treatment Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insomnia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Treatment Drugs Overall Market Size
2.1 Global Insomnia Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Insomnia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Treatment Drugs Players in Global Market
3.2 Top Global Insomnia Treatment Drugs Companies Ranked by Revenue
3.3 Global Insomnia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insomnia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Insomnia Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Prescription Sleep Aids
4.1.3 Over the Counter (OTC) Sleep Aids
4.2 By Type - Global Insomnia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Insomnia Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Others
5.2 By Application - Global Insomnia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Insomnia Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Insomnia Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Insomnia Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Insomnia Treatment Drugs Revenue, 2017-2028
6.3.2 US Insomnia Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Insomnia Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Insomnia Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Insomnia Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Insomnia Treatment Drugs Market Size, 2017-2028
6.4.3 France Insomnia Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Insomnia Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Insomnia Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Insomnia Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Insomnia Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Insomnia Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Insomnia Treatment Drugs Revenue, 2017-2028
6.5.2 China Insomnia Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Insomnia Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Insomnia Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Insomnia Treatment Drugs Market Size, 2017-2028
6.5.6 India Insomnia Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Insomnia Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Insomnia Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Insomnia Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Insomnia Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Insomnia Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Insomnia Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Insomnia Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 F.Hoffman La-Roche AG
7.1.1 F.Hoffman La-Roche AG Corporate Summary
7.1.2 F.Hoffman La-Roche AG Business Overview
7.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Major Product Offerings
7.1.4 F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 F.Hoffman La-Roche AG Key News
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Corporate Summary
7.2.2 Merck & Co. Inc. Business Overview
7.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Major Product Offerings
7.2.4 Merck & Co. Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Merck & Co. Inc. Key News
7.3 Mylan N.V.
7.3.1 Mylan N.V. Corporate Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Insomnia Treatment Drugs Major Product Offerings
7.3.4 Mylan N.V. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Mylan N.V. Key News
7.4 Pfizer, Inc.
7.4.1 Pfizer, Inc. Corporate Summary
7.4.2 Pfizer, Inc. Business Overview
7.4.3 Pfizer, Inc. Insomnia Treatment Drugs Major Product Offerings
7.4.4 Pfizer, Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Pfizer, Inc. Key News
7.5 Pernix Therapeutics
7.5.1 Pernix Therapeutics Corporate Summary
7.5.2 Pernix Therapeutics Business Overview
7.5.3 Pernix Therapeutics Insomnia Treatment Drugs Major Product Offerings
7.5.4 Pernix Therapeutics Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Pernix Therapeutics Key News
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Corporate Summary
7.6.2 Sanofi S.A. Business Overview
7.6.3 Sanofi S.A. Insomnia Treatment Drugs Major Product Offerings
7.6.4 Sanofi S.A. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Sanofi S.A. Key News
7.7 Takeda Pharmaceutical Company Ltd.
7.7.1 Takeda Pharmaceutical Company Ltd. Corporate Summary
7.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Takeda Pharmaceutical Company Ltd. Key News
7.8 Sumitomo Dainippon Pharma Co., Ltd
7.8.1 Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
7.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Major Product Offerings
7.8.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Sumitomo Dainippon Pharma Co., Ltd Key News
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News
7.10 Vanda Pharmaceuticals, Inc.
7.10.1 Vanda Pharmaceuticals, Inc. Corporate Summary
7.10.2 Vanda Pharmaceuticals, Inc. Business Overview
7.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Major Product Offerings
7.10.4 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Vanda Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Insomnia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Insomnia Treatment Drugs Market Drivers in Global Market
Table 3. Insomnia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Insomnia Treatment Drugs in Global Market
Table 5. Top Insomnia Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Insomnia Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Insomnia Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Insomnia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Insomnia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Insomnia Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Insomnia Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Insomnia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Insomnia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Insomnia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. F.Hoffman La-Roche AG Corporate Summary
Table 31. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product Offerings
Table 32. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co. Inc. Corporate Summary
Table 34. Merck & Co. Inc. Insomnia Treatment Drugs Product Offerings
Table 35. Merck & Co. Inc. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Mylan N.V. Corporate Summary
Table 37. Mylan N.V. Insomnia Treatment Drugs Product Offerings
Table 38. Mylan N.V. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer, Inc. Corporate Summary
Table 40. Pfizer, Inc. Insomnia Treatment Drugs Product Offerings
Table 41. Pfizer, Inc. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pernix Therapeutics Corporate Summary
Table 43. Pernix Therapeutics Insomnia Treatment Drugs Product Offerings
Table 44. Pernix Therapeutics Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi S.A. Corporate Summary
Table 46. Sanofi S.A. Insomnia Treatment Drugs Product Offerings
Table 47. Sanofi S.A. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Takeda Pharmaceutical Company Ltd. Corporate Summary
Table 49. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product Offerings
Table 50. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Sumitomo Dainippon Pharma Co., Ltd Corporate Summary
Table 52. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product Offerings
Table 53. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 55. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Vanda Pharmaceuticals, Inc. Corporate Summary
Table 58. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product Offerings
Table 59. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Insomnia Treatment Drugs Segment by Type in 2021
Figure 2. Insomnia Treatment Drugs Segment by Application in 2021
Figure 3. Global Insomnia Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insomnia Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insomnia Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Insomnia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co. Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan N.V. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer, Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pernix Therapeutics Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi S.A. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
